The unique Medicago plant-based Covid-19 Canadian vaccine
Clinical Safety & Pharmacovigilance during product life cycle
Key concepts of pharmacovigilance throughout the medical product development cycle and clinical safety of the unique Medicago’s plant-based vaccine against COVID-19.
June 21, Monday, 4:00 pm EST
Speaker: Dr Asif Mahmood, MD, MPH, MBA, Chief Safety Officer
VP Global Clinical Safety at Medicago
Host: Bersabeh Bouramand, PharmD, MBA,
Clinical Affairs Liaison, CRA School Montreal
The Medicago vaccine is currently in end-Phase III clinical trial. Despite his extremely overcharged schedule, Dr Mahmood generously agreed to spare some of his time to speak to aspiring clinical research professionals. We are very grateful for his altruism.
Free event. Recording available if busy at that hour
